We are live on ! Find out more
WM

WS Management Portfolio holdings

AUM $1.14B
1-Year Est. Return 139.27%
This Fund
S&P 500
This Quarter Est. Return
+7.8%
1 Year Est. Return
+139.27%
3 Year Est. Return
+309.04%
5 Year Est. Return
+400.83%
10 Year Est. Return
+1,509.99%
AUM
$3.54B
AUM Growth
-$241M
Cap. Flow
-$343M
Cap. Flow %
-9.68%
Top 10 Hldgs %
60.83%
Holding
90
New
24
Increased
12
Reduced
37
Closed
15
Avg Time Held Equity + Options
7.5 quarters
Top 10 Avg Time Held Equity + Options
7.3 quarters
Top 20 Avg Time Held Equity + Options
8 quarters
Avg Time Held Equity only
8.5 quarters
Top 10 Avg Time Held Equity only
8.3 quarters
Top 20 Avg Time Held Equity only
9.1 quarters

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$138M
2
RGNX icon
Regenxbio
RGNX
+$40.1M
3
CMG icon
Chipotle Mexican Grill
CMG
+$21.2M
4
HMHC
Houghton Mifflin Harcourt Company
HMHC
+$15.9M
5
SMG icon
ScottsMiracle-Gro
SMG
+$15.8M

Top Sells

Rank Stock Value
1
MU icon
Micron Technology
MU
+$226M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$100M
3
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$53M
4
ALB icon
Albemarle
ALB
+$37.6M
5
META icon
Meta Platforms (Facebook)
META
+$28.4M

Sector Composition

Rank Sector Weight
1 Financials 27.68%
2 Miscellaneous 19.03%
3 Technology 15.65%
4 Consumer Discretionary 8.82%
5 Communication Services 7.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
MHK icon
51
Mohawk Industries
MHK
$7.95B
$8.27M 0.23%
38,605
-6,995
-15% -$1.53M
2016 Q4
6 quarters
XOM icon
52
ExxonMobil
XOM
$708B
$7.02M 0.2%
84,835
-5,490
-6% -$437K
2013 Q2
20 quarters
TSLA icon
53
Tesla
TSLA
$1.49T
$6.86M 0.19%
+300,000
New +$6.1M
2018 Q2
0 quarters
BKI
54
DELISTED
Black Knight, Inc. Common Stock
BKI
$6.75M 0.19%
126,061
-12,757
-9% -$642K
2017 Q4
2 quarters
BMRN icon
55
BioMarin Pharmaceuticals
BMRN
$10.7B
$6.15M 0.17%
+65,300
New +$5.72M
2018 Q2
0 quarters
CPB icon
56
Campbell Soup
CPB
$5.69B
$5.75M 0.16%
+141,850
New +$5.52M
2018 Q2
0 quarters
BLUE icon
57
DELISTED
bluebird bio
BLUE
$5.28M 0.15%
+2,597
New +$5.92M
2018 Q2
0 quarters
ONCE
58
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$5.25M 0.15%
+63,400
New +$4.89M
2018 Q2
0 quarters
F icon
59
Ford
F
$47.9B
$5.14M 0.15%
464,310
-52,990
-10% -$607K
2013 Q2
20 quarters
HA icon
60
DELISTED
Hawaiian Holdings, Inc.
HA
$5.1M 0.14%
141,859
-108,141
-43% -$4.17M
2018 Q1
1 quarter
ABEO icon
61
Abeona Therapeutics
ABEO
$280M
$4.45M 0.13%
+11,120
New +$4.86M
2018 Q2
0 quarters
CLLS icon
62
Cellectis
CLLS
$119M
$4.34M 0.12%
+153,559
New +$4.57M
2018 Q2
0 quarters
QURE icon
63
uniQure
QURE
$1.51B
$4.29M 0.12%
+113,500
New +$3.63M
2018 Q2
0 quarters
WVE icon
64
Wave Life Sciences
WVE
$646M
$4.28M 0.12%
+112,000
New +$4.82M
2018 Q2
0 quarters
RARE icon
65
Ultragenyx Pharmaceutical
RARE
$1.51B
$4.16M 0.12%
+54,100
New +$3.49M
2018 Q2
0 quarters
CVNA icon
66
Carvana
CVNA
$42.8B
$3.74M 0.11%
+450,000
New +$2.71M
2018 Q2
0 quarters
RGNX icon
67
CALL
Regenxbio
RGNX
$513M
$3.59M 0.1%
+50,000
New +$2.39M
2018 Q2
0 quarters
ADAP
68
DELISTED
Adaptimmune Therapeutics
ADAP
$3.52M 0.1%
+296,783
New +$3.7M
2018 Q2
0 quarters
AUD
69
DELISTED
Audacy, Inc.
AUD
$3.47M 0.1%
459,188
+74,344
+19% +$630K
2017 Q3
3 quarters
SGMO icon
70
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$3.45M 0.1%
+243,000
New +$4.04M
2018 Q2
0 quarters
CRSP icon
71
CRISPR Therapeutics
CRSP
$4.98B
$3.35M 0.09%
+57,000
New +$3.25M
2018 Q2
0 quarters
NTLA icon
72
Intellia Therapeutics
NTLA
$1.76B
$3.28M 0.09%
+120,000
New +$2.91M
2018 Q2
0 quarters
EDIT icon
73
Editas Medicine
EDIT
$422M
$3.11M 0.09%
+86,765
New +$3.07M
2018 Q2
0 quarters
SLDB icon
74
Solid Biosciences
SLDB
$719M
$2.84M 0.08%
+5,313
New +$1.63M
2018 Q2
0 quarters
GG
75
DELISTED
Goldcorp Inc
GG
$1.9M 0.05%
138,505
-12,395
-8% -$172K
2013 Q2
20 quarters
1 2
3
4

Similar funds

SIM
Symetra Investment Management Farmington, Connecticut $1.14B AUM 10.76% 1-Year Est. Return
CAM
Carret Asset Management New York $1.14B AUM 35.33% 1-Year Est. Return
VCP
Vista Capital Partners Portland, Oregon $1.14B AUM 21.34% 1-Year Est. Return
LMGAM
Liberty Mutual Group Asset Management Boston, Massachusetts $1.15B AUM 29.1% 1-Year Est. Return
GG
Gleason Group Prospect, Kentucky $1.15B AUM 21.11% 1-Year Est. Return
DWS
Discipline Wealth Solutions Greenville, South Carolina $1.15B AUM 20.96% 1-Year Est. Return
MIG
McGuire Investment Group Wakefield, Rhode Island $1.14B AUM 79.59% 1-Year Est. Return
SC
Shellback Capital Boston, Massachusetts $1.14B AUM 49.89% 1-Year Est. Return

WS Management's Q2 2018 Portfolio in Review

As of Q2 2018, WS Management held 90 positions worth $3.54B, down 6.4% from $3.79B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

WS Management withdrew a net $343M in Q2 2018, closing 15 positions and reducing 37 holdings. Its most notable exit was Invesco QQQ Trust, an estimated $100M position sold in full.

By sector, the portfolio is most concentrated in Financials at 28% of assets, down from 30% a quarter earlier, followed by Miscellaneous and Technology.

Against the trend, WS Management opened a new position in ScottsMiracle-Gro worth $15.7M.

  • WS Management's largest Q2 2018 buy was ScottsMiracle-Gro: 189,224 shares worth $15.7M.
  • WS Management added most to Alphabet (Google) Class A in Q2 2018, an estimated $138M increase.
  • WS Management's biggest Q2 2018 reduction was Micron Technology, cutting an estimated $226M.
  • WS Management fully exited Invesco QQQ Trust in Q2 2018, selling an estimated $100M.
  • WS Management's ten largest holdings make up 61% of its $3.54B portfolio in Q2 2018.
  • WS Management opened 24 new positions and closed 15 in Q2 2018.
  • WS Management's portfolio value fell 6.4% quarter-over-quarter to $3.54B.

Based on WS Management's 13F filing for Q2 2018, filed 13 Aug 2018.